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1. Introduction   
 
In 1977, Steptoe and Edwards successfully carried out the pioneering work of 
developing a human embryo outside the human body. On 25th July 1978, the world’s 
first In Vitro Fertilization (IVF) baby, Louise Brown was born. The first German IVF 
baby was born at the University Department of Obstetrics and Gynaecology in 
Erlangen in 1982, followed by the University Hospital of Schleswig Holstein, Luebeck 
and Kiel in the same year. Since then, more that 8 million IVF babies have been born 
all over the world. Over the years, there have been numerous developments in the 
form of improvement of stimulation schemes, culture systems, oocyte pick up 
methods, embryo transfer and new freezing techniques. Several patients with male 
factor infertility were benefited with the development of Intra Cytoplasmatic Sperm 
Injection (ICSI) in the 90s. Both IVF and ICSI together are referred to as Assisted 
Reproductive Technology (ART). With the evolution of ART, there was parallel 
increase in the pregnancy rates world-wide. In Germany the number of oocyte 
retrievals have increased from 742 in 1982 to 64,441 in 2018 (Figure 1) with 4.5% of 
the births (12,813) in 2018 in Germany being from ART treatments(1).  
 
 
Figure 1: Number of Assisted Reproductive Technology cycles in Germany from 
1982 to 2018. Adapted from the German IVF-Registry (D.I.R) 2018, Journal of 
Reproductive Medicine and Endocrinology 
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In 1988 it was hypothesised that extending culture of the embryo beyond the typical 
2–3 days in vitro, to 5 days (blastocyst culture) would help identify those embryos 
capable of converting their development from stored maternal messages to an 
activated embryonic genome (2). Hence, assisting in transferring only those embryos 
capable of implantation and pregnancy. Culture media failed to take into account the 
changing physiology and requirements of the embryo and it was not until 1996 that a 
human blastocyst could be cultured successfully in-vitro. Since then, blastocyst 
culture has become the standard for the most successful labs internationally.  
While most countries laws or guidelines allow all fertilized oocytes to develop in 
culture, allowing the developmentally competent embryos to be transferred or frozen, 
the ART legislation of Germany - Embryo Protection Act (ESchG- Embryonen-
Schutz-Gesetz), 1990 bans embryo selection. The act states that only that many 
fertilized oocytes are allowed to be developed in culture that are going to be 
transferred. Hence, if a couple desires 2 embryos to be transferred and had 10 
oocytes retrieved and 8 fertilized, then, only 2 fertilized oocytes could be cultured. 
The remaining 6 fertilized oocytes could be frozen or discarded or a combination of 
both could be performed.  
 
In approximately 2008/2009 the so-called German Middleway (DMW- Deutscher 
Mittelweg) was used by many southern provinces of Germany whereby, if a couple 
wished, as many fertilized oocytes as necessary could be cultivated to enable 
identification of 2 viable embryos for transfer (3). Although complicated, many ART 
centres to adopted the DMW while planning a couple’s treatment due to the multiple 
advantages of an extended culture of fertilized oocytes and enabling the 
identification of the most viable embryos on day 5 for transfer to improve pregnancy 
rates. In 2019 the  German National Academy of Sciences Leopoldina and Union of 
the German Academies of Sciences published, “Reproductive medicine in Germany 
– towards an updated legal framework”, in which it stated that many of the 
developments in ART now could not have been predicted in the 80s and hence, it is 
important to have new regulations with the best possible and least invasive 
treatments, giving due consideration to the rights of all parties, including the future 
children. Although there is a change word-wide to move to blastocyst transfers to 
improve pregnancy rates, it is still a topic of debate. Blastocyst transfer is surrounded 
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by controversy due to the advantages and disadvantages associated with it. 
Especially in Germany, with the strong ART Legislation and day 2/3 transfer being 
the precedent, it is necessary to critically evaluate the place of blastocyst transfer.   
 
In the Reproductive Unit of the University Clinics of Schleswig Holstein, Kiel, 
Germany, the rule in the newly re-opened IVF Lab in 2014 was a day 2 or day 3 
embryo transfer according to the ESchG. Hence, after performing the fertilization 
check on day 1, if 2 embryos we planned to be transferred, 2 were left in culture and 
the rest were frozen on day 1. Due to this, there was no reason to extend the culture 
to Day 5 except in rare cases. Eventually, we adopted the DMW which allowed for 
the culture of a minimal number of fertilized oocytes to day 5 to perform a successful 
Blastocyst transfer. Over 5 years, we increased the number of day 5 transfers while 
changing culture conditions and found an increase in our pregnancy rates.  
It is the aim of the present study to critically analyse how day 2 or 3 embryo culture 
compared to day 5 embryo culture and transfer affected  our pregnancy rates and to 
discuss the potential factors in our lab that improved embryo culture conditions and 























A prospective study was performed to analyse 1126 IVF/ICSI cycles performed 
between   1.2.2014 to 30.12.2018 at the University Reproductive medical unit in the 
UKSH (Universitätskliniken Schleswig-Holstein), Kiel, Germany to study the impact 
of blastocyst culture on pregnancy rates and what influences it. 
 
The inclusion criteria were patients of the University Reproductive Medical Unit who 
underwent stimulation for oocyte retrieval, had oocyte retrieval by trans-vaginal 
follicular puncture, had fertilization after IVF/ICSI and had an embryo transfer in the 
same cycle. When an embryo transfer is performed in the same cycle as the 
stimulation, it is called a “fresh embryo transfer”. 
 
The following patients were excluded from the study: 
1. Patients who had stimulation in whom we could not retrieval any mature oocytes 
2. Patients who did not have a fresh embryo transfer 
3. Patients who had embryo arrest or abnormal embryos 
4. Patients for social freezing and fertility preservation 
5. Patients in whom ICSI was performed with testicular aspirated sperm and not with 
ejaculated sperm. 
 
Out of the 1126 ART cycles, 791 had a day 2/ day 3 embryo transfer and 335 had a 
day 5 embryo transfer.  
 
2.2 Ovarian stimulation and Oocyte retrieval 
 
When a couple was selected for an IVF/ICSI cycle, controlled ovarian 
hyperstimulation was performed using recombinant FSH (Gonal-F, Bemfola, 
Rekovelle, Puregon oder Ovaleap) or urinary extracted HMG (Menogon, Pergoveris). 
Pituitary down-regulation was achieved by GnRH antagonist (Orgalutran (0,25mg/ 
0,5ml)) from Day 6 of the stimulation and the dose (125-450 IU/day) was adjusted 
based on the ultrasound monitoring of follicular growth. During follicular monitoring, 
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when at least 3 of the follicles were >17mm in diameter, a HCG trigger of Ovitrelle 
(6500 IU) or alternatively Brevactid (5000/ 10.000 IU) was given. Trans-vaginal 
ultrasound guided oocyte retrieval either with or without anaesthesia was performed 
36 hours after triggering with HCG. Oocyte retrievals were planned on Mondays, 
Wednesdays and Fridays while the embryo transfers were planned for day 2/3/5, 
depending on the previous discussion with the couple and the embryo development. 
 
2.3 Laboratory techniques 
 
The Cumulus Oocyte Complexes (COCs) retrieved during follicular aspiration were 
collected in culture media (GM501Cult with Gentamicin, Gynemed) in a culture dish 
(OOPW-CW05-1, Oosafe) and placed in the incubator under strict temperature, pH 
and clean room conditions. The partner’s fresh ejaculated semen sample was 
parallelly processed by a standardised protocol for density gradient (GM501 
Gradient 45% and 90%, Gynemed). IVF or ICSI was performed depending on the 
sperm characteristics. If the sperm concentration was >=15million and the 
progressive motility of the sperm was >= 32%, a conventional IVF (25,000 sperms 
were placed on each COC) was performed. In those with abnormal semen 
parameters, the COCs were denuded using hyaluronidase (GM501Hyaluronidase, 
Gynemed) and graded as immature or mature oocytes. ICSI was performed on the 
mature oocytes using a micromanipulator while the immature oocytes were 
discarded. The process in the laboratory and the development of the embryo in-vitro 
is summarised in figure 2. 
 
The patients had to make 3 decisions before starting stimulation: 
1. If they wanted to have a regular Day 2/3 (Cleavage stage) embryo transfer or an 
extended culture and a day 5 (blastocyst stage) transfer.  
2. The number of embryos that would be transferred – 1, 2 or 3.  
3. If they preferred culture in a time lapse incubator in which the development of the 
embryos could be monitored every 5 minutes by a camera system without disturbing 







Figure 2: Overview of IVF/ICSI and embryo development in the Lab.  COC: Cumulus 






Considering the day of IVF or ICSI as day 0, every oocyte after IVF or ICSI was 
evaluated and managed as follows: 
 
1. Day 1 - Fertilization check and freezing 
After 16-18 hours of the ICSI, i.e. on Day 1 every oocyte was checked for the 
presence of 2 Pro-Nuclei (PN) which signifies normal fertilization. When no PN or 
more than 2 PN were observed, these oocytes were considered abnormal and 
discarded. 
 
When the patient wanted a Day 2/3 transfer, if 2 embryos were planned to be 
transferred, then 2 optimal fertilized oocytes were chosen based on the zygote 
morphology scoring system proposed by European Society of Human Reproduction 
and Embryology 
(ESHRE) (4) and were left in culture. The rest of the 2PN stage oocytes were either 
frozen or discarded depending on the patient’s desire. For example, if the patient 
wanted a single embryo transfer, then 1 fertilized oocyte was left in culture and if 3 
embryos were desired, then 3 were left in culture. 
 
When the patient wanted a day 5 transfer, depending on the age of the patient, 
number of embryos to be transferred and the previous ART cycles of the patient, we 
cultured between 2 and 6 2PN stage oocytes till Day 5 and transferred the 
developmentally appropriate embryos. If more than the agreed upon number of 
embryos to be transferred developed into blastocysts, the extra embryos were 
frozen.  
 
2. Day 2 – Embryo check or embryo transfer 
On Day 2, the embryos were graded according to the ESHRE consensus workshop 
(4) and transferred if a cleavage stage embryo transfer was planned. They were left 
in culture if a Day 3 or Day 5 embryo transfer was planned. 
3. Day 3 – Embryo check or embryo transfer 
On Day 3, the embryos were graded according to the ESHRE consensus workshop 
(4) and transferred if a cleavage stage embryo transfer was planned. They were left 
in culture if a Day 5 embryo transfer was planned. 
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4. Day 4 – Development of morula 
On Day 4, the embryo was graded according to the ESHRE consensus workshop 
(4). 
 
5. Day 5 – Development of the blastocyst stage and embryo transfer  
On day 5, the embryos were graded according to the ESHRE consensus workshop 
(4). The development of the trophectoderm reflects the embryos ability to implant 
while the development of the inner cell mass reflects the ability of the foetus (5). 
There is an increase in the cavity of the blastocyst during development only if the 
trophectoderm cells function optimally, indirectly demonstrating of embryo 
competence. Based on the morphological grading of the blastocyst (Figure 3), they 
were divided into ideal embryos and not-deal embryos. Ideal embryos had, at least a 
grade 3 for the blastocoel cavity, a grade B for the inner cell mass and a grade B for 
the trophectoderm. Any day-5 embryos not reaching these minimum criteria was 
considered a non-ideal embryo. If the embryos had arrested in development and did 
not reach the blastocyst stage, they were discarded.  
 
 





2.4 Culture Systems 
 
An incubator (Figure 4) is a sterile chamber in which the conditions inside the uterus 
are simulated to foster the development of an embryo outside the body. Hence, for 
optimal growth of an embryo, an incubator should maintain its temperature and pH of 
the culture media by maintaining the CO2 level in its chamber. When an incubator’s 
door is opened to remove a culture dish (Figure 4d and 4e) of patient’s embryos to 
check their progress or to change the culture media or to transfer the embryos, the 
environment in the incubator changes causing stress to the growing embryo. The 
smaller the chamber of the incubator, the faster it recovers hence, exposing the 
growing embryo to lesser stress.  
 
Figure 4: Different incubators and culture dishes used in the Lab. Incubators used for 
culture of embryos (a,b,c); Culture dishes used for culture of embryos in the 
incubators (d,e) 
 
A conventional incubator (Figure 4a) is a large incubator in which many patient’s 
embryos in culture dishes can be simultaneously cultured. Hence, when multiple 
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patient’s embryos are cultured simultaneously, a single opening of the incubator for 
evaluating the embryos of one patient affects multiple patients embryos.  
 
A bench-top incubator (Figure 4b) has 2-8 chambers in which 2-4 patient’s embryos 
can be cultured in each chamber. The advantage is that due to its small chamber 
size, it has faster recovery and only 1-4 patient’s embryos are affected with a single 
chamber opening. In the conventional and bench-top incubators, the embryos were 
cultured in 30mm dishes with 50µl drops with 1-3 oocytes per drop (Figure 4d).  
 
A time-lapse incubator (Figure 4c) is a bench-top incubator in which a single 
chamber can accommodate only a single patient and it has an attached camera 
system which takes pictures of each embryo every 5-15 minutes. Hence, the 
advantage is that, with every chamber opening only one patient is affected. As the 
culture dish need not be removed from the incubator to morphologically grade an 
embryo, it prevents excessive exposure to the environment outside the incubator. A 
time lapse incubator can be used for 6-24 patients simultaneously as it has multiple 
chambers.  
 
The Esco MIRI® Time-Lapse Incubator (TL6) incubator is the time lapse incubator 
that was used in this study. It has 6 individual chambers for 6 patients with an 
exclusively designed culture dish – “culture coin” (Figure 4e) for each patient. The 
culture coin has 12 microwells to enable each embryo to be separately placed and 
positioned in the field of camera view. The system was set to take a single picture 
every 5 minutes to provide continuous surveillance of all embryos in “real time” 
without disrupting the culture, allowing important events to be observed and assist in 
identifying healthy embryos.  
 
Over the period of 5 years, our lab changed its culture technique 3 times to stay 
abreast with the latest technology available for embryo culture. From 2013 to 2018, 
all three incubators were used for patients parallelly. The decision to use a particular 
incubator for a particular patient was completely random. In 2014 all the embryos 
were cultured in a conventional incubator (Heracell™ 240i CO2 Incubator, Thermo 
Fischer Scientific). In 2015, a bench top incubator (IVF Cube, AD-3100, Astec) with 
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reduced oxygen culture was parallelly introduced. In 2017, a time-lapse incubator 
(Miri-TL, Esco) also with reduced oxygen culture was added.  
 
In the conventional incubator, around 6%CO2 was the only gas used for maintaining 
the pH of the culture media. 94% of the remaining gas in the incubator was 
atmospheric air. Hence, the oxygen concentration was that of atmosphere – 21%. In 
the bench-top and time lapse incubators, along with 6% CO2, 5% O2 form the 
atmosphere was maintained by adding 89% nitrogen gas to the incubator. As these 
incubators had 3 different gasses (CO2, O2 and N2) in them, they are also called 
“triple gas” culture system. As the oxygen concentration was lower than the 
conventional incubator, they are also called “reduced oxygen culture”.  
 
2.5 Embryo transfer and verification of pregnancy 
 
On the day of embryo transfer, the cleavage embryos and blastocysts were graded 
according to the ESHRE consensus workshop (4) categorised into ideal and non-
ideal embryos. The embryo transfer was performed under abdominal ultrasound 
guidance by an after-load technique. i.e. after the outer catheter was placed by the 
clinician through the cervix of the patient till the inner cervical os, the inner catheter 
was loaded with the embryos to be transferred and brought to the clinician by the 
embryologist. Following this, the clinician placed the embryos under abdominal 
ultrasound guidance at a distance of about 1.5cm from the fundus of the uterus. 
Conventional luteal support was followed.   
 
A serum beta-HCG measurement was performed 14 days after the transfer to 
confirm pregnancy. A beta-HCG of more than 20 IU was considered positive for 
pregnancy. Some of the patients were followed up till the delivery and the week of 
gestation, weight, sex and condition of the baby was documented. 
 
When the beta-HCG was positive, the patient was considered to be pregnant. When 
a foetal heart was documented on ultrasound between the 7th and 9th week of 
pregnancy, it was considered a clinical pregnancy. When the pregnancy did not 
continue beyond the positive beta-HCG or failed after a foetal heart was detected, it 
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was excluded from the evaluation and added to a common group of “abortions”. 
Thus, biochemical pregnancies and abortions were recorded together.  
 
2.6 Statistical analysis 
 
Data analysis was performed using computer software JASP(6) for descriptive 
statistics, independent sample t-tests, χ2 test and fisher’s exact tests . Quantitative 
data was analysed using t-test and categorical data was analysed using χ2 test or 
Fisher’s exact test. Online Chi-Square Test calculator (www.socscistatistics.com) 
was used when a contingency table had more than 2 rows and 2 columns of 
categorical variables to determine if there were non-random associations between 
the variables. Fisher's Exact test was used when the frequency was less than 5. A p 
value of less than 0.05 was considered statistically significant. 
While comparing descriptive statistics between the two groups for bias, Welch test 
was used if the distribution was normal and if not, the Mann-Whitney test was used.  
The data of binomial logistic regression analysis was computed using JAMOVI 
(1.2.16 current). It was entered in Excel to plot the regression analysis graphs by 
using the formula P(Y = 1) = 1/(1 + exp(-(Intercept + “coefficient for year”*year + 
“coefficient for method”*method))). All the variables that were assessed were 
included in all the logistic regression analysis in order to correct any probable bias. 
The variables were: Age of the woman, number of IVF attempts, number of oocytes 
retrieved, mature oocytes, immature oocytes, fertilized oocytes, number of embryos 
transferred, doctor who performed the oocyte retrieval and embryo transfer, 
embryologist who performed the oocyte screening, ICSI/IVF and embryo transfer, 
culture incubator used and status of the catheter after the embryo transfer. The 
logistic regression analysis data was accepted only when the Nagelkerke R2 value 
was >0.2. 
G*Power (7) was used to compute statistical power analyses for many 







3.1 General comparison of pregnancy rates 
 
Table 1 gives the characteristics of the patients in the study - the of age, BMI, the 
number of ART cycles the patient had previously (ART attempt number), number of 
cumulus oocyte complexes retrieved (No. of COCs), number of mature oocytes (M2), 
number of normal fertilized oocytes (2PN), number of embryos transferred. 
 








1.8 1 1.2 1 10 
No. Of 
COCs 
9.5 9 5.7 1 31 
No. Of M2 6.9 7 3.5 1 25 




1.9 2 0.54 1 3 
 
Table 1: Descriptive statistics of the patients. COC: Cumulus oocyte complexes; PN: 
Pro-Nucleus; IVF: In-vitro fertilization; ICSI: Intra cytoplasmic sperm injection  
 
The reproductive unit of the university hospital steadily increased the number of a 
blastocyst cultures from 21% in 2014 to 44% in 2018 as clearly seen in Figure 5. 
 
Pregnancy outcomes of the different groups are shown in Table 2. The overall 
outcome showed a pregnancy rate between 29% – 32%. 
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Figure 5: Percentage of blastocyst cultures compared to cleavage stage transfers 
each year from 2014 to 2018. 
 
 




Day 2  146 350 495 29% 
Day 3  84 213 296 28% 
Cleavage stage 
(Day 2 + Day 3) 
230 561 791 29% 
Day 5 transfer 106 229 335 32% 
 
Table 2: Comparison of pregnancy rates based on day of transfer of combined data 
from 2014 to 2018  
 
A comparison showed that there was no statistical difference (p=0.75) in pregnancy 
rates between the Day 2 (n=495) and the Day 3(n=296) transfer groups. When Day 
2 and Day 3 transfers were combined as cleavage stage transfer group(n=791) and 
compared with the blastocyst stage, there was no significant difference (p=0.39) in 











1 2 3 4 5





cleavage % each year blast % each year
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Figure 6: 100% stacked bar depiction of the pregnancy rate of total cleavage stage 
transfers (n=791) compared with total blastocyst transfers (n=335) from 2014 to 
2018. 
 
Further analysis of the pregnancy rates in each year from 2014 to 2018 (Table 3) 
showed no statistical difference in the pregnancy rates between the years for Day 2 
transfer (p=0.96), Day 3 transfer (p=0.67) and combined cleavage stage transfer 
(p=0.45). When pregnancy rates of cleavage transfers were compared with day 5 
transfers for each individual year, no significance was found (p value ranging from 
0.06 to 0.73). However, as Figure 7 clearly depicts the statistical difference between 
the pregnancy rates of blastocyst transfer between the years with a chi-square 
statistic of 12.97 and a p-value of 0.01 (Power or 80.6%). On individually analysing 
the difference between the years, it was found that the most significant (p=0.005) 
improvement in pregnancy rates were between 2017 and 2018 for blastocyst 
transfer. 
 
Based on the significant findings in the comparison of individual years, a logistic 
regression analysis was performed without taking into account any possible bias. 
The Nagelkerke R2 was 0.04 (Figure 8). The graph indicated an improvement in the 
pregnancy rates over 5 years with Day 5 having better pregnancy rates than 
cleavage stage transfer. The calculated odds ratio of 1.105 implied that per year 
there was an increase in the pregnancy rates by 1.1 times.  
 















 2014 2015 2016 2017 2018 Grand total 
Day 2 transfers 94 91 101 111 98 495 
Pregnant 32 20 27 30 20 139 
Percentage 
Pregnant 
34% 22% 26.7% 27% 30.6% 28.1% 
Day 3 transfers 42 48 69 78 59 296 
Pregnant 9 10 20 23 18 80 
Percentage 
Pregnant 
21.4% 20.8% 29% 29.5% 30.5% 27% 
Cleavage transfers 136 139 170 189 157 791 
Pregnant 41 30 47 53 38 219 
Percentage 
Pregnant 
30% 21% 27.6% 28% 24% 26% 
Day 5 transfers 37 44 56 73 125 335 
Pregnant 7 13 14 16 52 102 
Percentage 
Pregnant 
18.9% 29.5% 25% 21.9% 41.6% 30.4% 
 
Table 3: Comparison of pregnancy rates in each year from 2014 to 2018 based on 
day of transfer. (Cleavage transfer is day 2 and day 3 transfer together) 
 
Figure 7: Stacked bar depicting for each year number of patients from 2014 to 2018 
who became pregnancy after day 5 and cleavage stage transfers  
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Figure 8: Graph of logistic regression curve showing pregnancy rates after cleavage 
transfer and blastocyst transfer from 2014 to 2018. No effect of probable bias was 
taken into account in this graph (Nagelkerke R2 = 0.04). 
 









Cleavage 35,9 4,7 23 48 
0.003 Welch 




Cleavage 1,8 1,2 1 10 
0.36 
Mann-
Whitney Day 5 1,9 1,2 1 7 
No. Of COCs 
 
Cleavage 8,6 5,6 1 32 
0.3 
Mann-
Whitney Day 5 12,0 5,2 2 35 
No. Of M2 
 
Cleavage 6,3 4,5 1 31 
<0.001 
Mann-
Whitney Day 5 8,9 4,0 2 27 
No. Of 2PN 
 
Cleavage 4,2 3,3 1 24 
<0.001 
Mann-





Cleavage 1,8 0,5 1 3 
<0.001 Welch 
Day 5 1,9 0,5 1 3 
 
Table 4: Comparison of basic characteristics of patients with the t-test value. p < 









2014 2015 2016 2017 2018
Cleavage Stage Transfer Day 5 Transfer
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An analysis comparing the baseline characteristics of the patients that could 
influence pregnancy rates found that age, number of oocytes retrieved, number of 
mature oocytes and number of oocytes fertilized showed a significant difference in 
the distribution between the cleavage and the blastocyst group (Table 4, Figure 9).  
 
Figure 9: Distribution plots of the frequency of distribution of the characteristics of the 
patients in the “Blastocyst transfer” (a,c,e,g,j,k) and “Cleavage transfer” (b,d,f,h,j,l) 
groups. a+b: distribution plot of age of the patients; c+d: ART attempt number; e+f: 
number of cumulus oocyte complexes (cocs) retrieved from each patient; g+h: 
number of mature oocytes retrieved from each patient; i+j: number of fertilized 
oocytes produced by each patient; k+l: number of embryos transferred in each 
patient 
 
3.2 Improvement of pregnancy rates from 2014 to 2018 
 
Based on the significant difference between the groups, we added this information 
and other information as explained in “2.4 Statistical analysis” to the logistic 
regression model to correct the possible bias. A logistic regression analysis (Figure 
10) was repeated with these variables to control their effect and it calculated the 
odds ratio to be 1.4, i.e. per year there was an increase in the pregnancy rates by 




Figure 10: Graph of logistic regression showing pregnancy rates after cleavage 
transfer and blastocyst transfer from 2014 to 2018 after influnce of various variables 
was taken into account. (Nagelkerke R2 = 0.2) 
 
Based on the fact that the pregnancy rates improved over the years, we broke down 
the data to identify the factors that changed over 5 years. We methodically examined 
the changes made in the clinics and in the lab separately. We explored the 
possibilities of change in patient characteristics, clinical treatment protocols, doctors, 
lab protocols, lab personnel and lab equipment over the years.  
 
There was no variation in the basic patient characteristics and no significant changes 
in the stimulation protocol, type of gonadotrophin used and, timing and medication 
used for final oocyte maturation. There was no change in the method or timing of the 
oocyte retrieval or embryo transfer procedure. There was no change in the luteal 
phase support provided. In the clinics and the lab, the same documented standard 
operating procedures were followed from 2014 to 2018. A statistical analysis of the 
pregnancy rates between both the doctors based on who performed the oocyte 
aspiration (p=0.07) and embryo transfer (p=0.38) was done and no significant 
difference was found. 
 
However, on scrutinizing the quality of embryos transferred (Figure 11), it was found 












2014 2015 2016 2017 2018
Cleavage Transfer Day 5 Transfer
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(p<0.001). On further inspection, the number of ideal cleavage embryos did not show 
a significant increase (p=0.1) but, the increase in the number of ideal blastocysts 
was significant (p<0.001). 
 
 
              
        (a)Total ideal embryos         (b) Ideal cleavage embryos     (c) Ideal day 5 embryos 
       (cleavage + day 5) 
 
Figure 11: Histograms depicting the number of ideal embryos transferred each year.  
(a) number of total ideal embryos (cleavage + day 5) transferred (b) number of ideal 
cleavage embryos (c) number of ideal day 5 embryos transferred 
 
Figure 12: Graph of logistic regression showing pregnancy rates after transfer of 
ideal and not ideal cleavage and blastocyst stage embryos from 2014 to 2018. 
Nagelkerke R2 = 0.46 
 
Ideal cleavage stage embryos had significantly (p=0.001) higher pregnancy rates 
than not-ideal cleavage stage embryos and logistic regression analysis (Figure 12a) 
showed an increase of pregnancy rates by 1.4 times each year. On the other hand, 
there was no statistically significant improvement in the number of ideal cleavage 





Figure 13: Logistic regression graph depicting the increase in number of day-5 ideal 
embryos and the decrease in the day 5 not-ideal embryos over 5 years 
 
The pregnancy rates improved also significantly (Figure 12b) with the transfer of an 
ideal day 5 embryos compared to a not-ideal day 5 embryos (p=0.001). The 
pregnancy rates increased by 4.8 times each year with the transfer of ideal day 5 
embryos. 
 
A logistic regression analysis (Figure 13) of the number of ideal day 5 embryos 
produced per year shows an increase by 1.5 times per year in the number of ideal 
day 5 embryos from 2014 to 2018. There was 4 times increase in numbers after the 
bench-top incubator was introduced and 8 times after the time-lapse incubator was 
introduced. While there was a rise in the number of ideal day 5 embryos, there was a 
simultaneous fall by 0.64 times in the number of not-ideal day 5 embryos per year. 
 
Extreme significance (Figure 14, p=0.0001, power 99%) was noticed when the 
pregnancy rates were compared between those patients who received a transfer of 
an ideal day 5 embryo and those that received a transfer of a not-ideal day 5 
embryo. 
 
While exploring the reason for increase in the number of ideal day 5 embryos leading 
to an improvement in the pregnancy rates, it was observed that there was no 
significant difference based on the embryologist who performed oocyte screening 
(p=0.37), the ICSI (p=0.68) or the embryo transfer (p=0.34).  
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 Pregnant Not pregnant Total 
Ideal Day 5 Embryo 102 175 277 
Not-ideal Day 5 
Embryo 
4 58 58 
 106 229 335 
Figure 14: Clustered column showing patients who got pregnant compared to those 
who did not get pregnant after transfer of an ideal or not-ideal day 5 embryo 
 
 
There was no significant change in the operating protocols in the lab. As the only 
significant change was addition of new culture incubators in the lab from 2014 to 
2018, on further investigation, a significant difference (Figure 15, p=0.01) was found 
in the number of ideal embryos that resulted from the culture in each incubator.  
45% of cleavage stage embryos were cultured in the conventional incubator while 
47% were cultured in the time-lapse incubator. 31% of the total day 5 embryos were 
cultured in the conventional incubator, 43% in the bench-top and 26% in the time-
lapse incubator. No significant change in the pregnancy rates was seen between 



















Figure 15: Percentage of Day 5 embryos that were “ideal” and “not-ideal” when 
cultured in different incubators. 89% of day 5 embryos in the time-lapse incubator, 
83% in the bench-top incubator and 75% in the conventional incubator were “ideal”. 
 
 
      
Figure 16: Pie diagrams showing the percentage of ideal and not ideal day 5 
embryos from each incubator. 
As depicted in Figure 16 and Table 5, the most ideal day 5 embryos were produced 
in the Bench-top / time-lapse incubators and the most not-ideal day 5 embryos were 
produced in the conventional incubator. Additionally, the comparison of the 
incubators with each other revealed there was no difference (Table 8, p=0.23) in the 
production on ideal embryos between the bench-top and the time-lapse incubators 
and the most significant difference (Table , p=0.004, power 84%) in the culture of 
ideal embryos was seen between the conventional and the time-lapse incubators.  






















Ideal Day 5 
embryo 





79 (75%) 27 (25%) 106 
Bench-top Incubator 71 (83%) 15 (17%) 86 
Time-lapse Incubator 127 (89%) 16 (11%) 143 




Table 5: Percentages and absolute numbers of ideal embryos that developed in 
each culture incubator. 
 
 
Figure 17: The relation between age of the patient and the percentage of (a) ideal 
blastocysts developed and (b) ideal cleavage stage embryos developed  
 
Figure 17 depicts that as the age of the woman increased, the percentage chance of 
development of an ideal blastocyst decreased from 90% for a woman below 30 
years to 71% for women above 40 years of age. For those between 30 and 39 years 
it was anywhere from 81 – 88%. Hence, the chance of a woman having an ideal 
blastocyst when a day 5 transfer was planned was above 70%. In contrast, in the 
cleavage stage transfer group, the percentage of ideal cleavage stage embryos 
developed were always below 64% irrespective of age.  
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Evaluation of the abortion rates (Figure 18b) brought to light that there was no 
significant difference (p=0.75) in the abortion rates between day-2, day-3, cleavage 
stage and blastocyst transfers. When individual years were compared (Figure 18a), 
there was also no significant difference (p=0.33) between the abortion rates. When 
an ideal day 5 embryo was transferred, there was no change (p=0.07) in the abortion 
rates compared to a not-ideal day 5 embryo. But, when an ideal and not-ideal 
cleavage stage embryo was transferred, it had a significant (p=0.008) influence on 
the abortion rates (Figure 19). 
 
Figure 18: 100% stacked column depicting abortion rates according to year (a) and 
day of transfer (b) 
 
 
Figure 19: 100% stacked bar depiction of the abortion rate with transfer of an ideal 
and not-ideal cleavage embryo. 
 
88% 90% 92% 94% 96% 98% 100%
Not-ideal Day 2/3
Ideal Day 2/3
Not-ideal Day 2/3 Ideal Day 2/3
Abort 706 366
Pregnancy continued 26 28
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Out of 282 pregnant patients that continued beyond 12 weeks of pregnancy, 197 
patients were followed up to live birth (power 19-31%). 143 had a cleavage stage 
transfer and 54 had a day 5 transfer. Out of the 34 twin births, 26 were from 
cleavage stage transfers and 8 from day 5 transfers. No statistical difference (Figure 
20) was found between birth method, preterm delivery rate, sex, weight, length and 
health of the baby between the day 5 transfer and the cleavage transfer group. 
There was no increased rate of twinning when 2 blastocysts were transferred 




Figure 20: 100% stacked column with chi square analysis of the obstetric outcomes 














4. Discussion of Results 
 
Today, more than 40 years after the first in-vitro fertilized baby was born, ART is 
available as a successful treatment option for infertile couples almost all over the 
world. Over 2.5 million cycles are performed per year resulting in 500,000 deliveries 
annually. Although more than 8 million children have been born, many challenges 
remain unanswered.  
Over the past decade, there appears to be a movement of the world ART community 
towards blastocyst culture, elective Single Embryo Transfers (eSET) and “Freeze all” 
strategy to improve the singleton live birth rates. Initially, Ovarian Hyperstimulation 
Syndrome (OHSS) was the most feared complication of ovarian stimulation. After the 
improved survival of embryos after vitrification, OHSS could be avoided by 
performing a “Freeze all” cycle where after development of the embryos, the best 
embryos are frozen and transferred in another cycle. Now, the complication of 
multiple pregnancy could be curtailed through eSET. The success of eSET and the 
“Freeze all” strategy to an extent depend on successful blastocyst culture. It has 
been identified that for 1-2 viable blastocysts to be produced, in 85% of the ART 
cycles, up to 6 fertilized oocytes have to be left in culture (3). Younger compared to 
older women would require fewer fertilized oocytes to be left in culture as the 
chances of developing a blastocyst mainly depends on the age and is a highly 
individualised decision.  
The success of an ART cycle depends on multiple clinical and lab factors. The 
couple’s medical characteristics, their clinical evaluation and the treatment given play 
important roles. In the lab, the number of oocytes retrieved, the different techniques 
used in the lab, the development of the patient’s embryos and the embryo transfer 
procedure are crucial to the success of an ART cycle. It is known that the age of the 
woman plays the most significant role in her chance of pregnancy in an ART cycle 
(8). The presence of uterine fibroids, polyps, adenomyosis, uterine septum, 
Polycystic Ovarian Syndrome (PCOS) , dermoid cysts, etc. also affects the outcome. 
In the male partner, the presence of reduced sperm counts (oligozoospermia), sperm 
motility (asthenozoospermia), sperm morphology (teratozoospermia) or a 
combination of the three affect the outcome of an ART cycle. The presence of a 
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varicocele, hydrocoele, diabetes, and sperm antibodies can certainly also affect the 
outcome (9).  
The initial days of embryonic development are driven by the maternal genome and 
from day 3 onwards, the embryonic genome is activated. Hence, prolonged culture 
enables self-selection of the embryos with higher implantation potential and accurate 
assessment. When many cleavage stage embryos are left in culture, in an average 
lab only 40% will develop into blastocysts and 60% will convert in an excellent lab 
(10). In-vivo, while the cleavage embryos develop in the fallopian tube, the blastocyst 
is the first stage of the embryo to be exposed to the uterine environment. Hence, the 
transfer of the embryo into the uterus at the blastocyst stage provides better 
physiological synchronization between the embryo and the endometrium (11) and 
minimizes the risk of expulsion due to exposure to increased uterine contractility 
which is present during the earlier days (12). It is known that blastocysts have, better 
cryo-survival (99%) and eSETs can be planned without decreasing the pregnancy 
rates while minimizing multiple gestation (13). In view of the “Embryo protection act”, 
if elective freezing of embryos was allowed, unnecessary freezing of fertilized 
oocytes with poor developmental potential could be avoided.  
When a blastocyst (day 5) transfer was planned, the morphology of 4 to 6 embryos 
were compared to choose 1, 2 or 3 embryos for transfer. Whereas, in the cleavage 
stage (day 2/3) transfer, the morphology of the 2PN stage was compared to choose 
1, 2, or 3 embryos for transfer. It is known that a good quality and poor quality 
grading of a  2PN oocyte had similar pregnancy rates (14) and embryo grading after 
the 2PN stage are more predictive of implantation than 2PN scoring (15). Therefore, 
there is a higher possibility of transferring good quality embryos in the patients opting 
for a blastocyst transfer (day 5) than those undergoing a cleavage stage transfer. 
While several studies including the 2016 Cochrane Systematic Review concluded 
that live birth rate was higher in the blastocyst transfer group compared to cleavage 
transfer group, there have been concerns raised about the genetic and epigenetic 
changes produced due to prolonged culture. While the cryo-survival of blastocysts 
are higher, prolonged culture is associated with lower embryos to freeze and 
increased risk of cancelation of transfer. It has been suggested that if 1% of women 
have no embryos to transfer at the cleavage stage, 2%-4% will have no embryos to 
 29 
transfer if a blastocyst transfer is planned (16). Exposing the embryos for longer 
periods to sub-optimal lab culture conditions might stress the embryos causing a fall 
in their implantation potential (17) while increasing the costs for no advantage. 
Blastocyst transfer has also been associated poor perinatal outcome (18), altered 
male to female ratio and increased risk on monozygotic twinning (19). While some 
studies stated that there was no increased risk of birth defects (20), some studies 
claimed an increase (21). The HEFA (Human Fertilisation and Embryology Authority) 
concluded that there might be an apparent reduction in risk of congenital anomalies 
with blastocyst transfer.  
 
There are several meta-analyses that find no superiority of blastocyst compared with 
cleavage-stage embryo transfer in clinical practice (22) and numerous that support 
the culture till day 5. Keeping in mind the German “Embryo Protection Law”, it had 
been the protocol in the lab, like many labs in Germany, to perform principally day 2/ 
3 transfers and rarely day 5 transfers.  
The primary aim of this study was to critically analyse if a predominant shift to 
blastocyst culture and transfer improved the chances of a patient getting pregnant 
when they were undergoing an ART cycle in the Reproductive Unit of the University 
Hospital, Kiel, Germany. The critical analysis included all the possible benefits and 
disadvantages of shifting from day 2/3 to day 5 culture and the changes made to 
have an optimal blastocyst rate. In the course of the evaluation, we realised that if 
the ideal blastocyst development rate was >60% (10), it was an excellent evaluation 
of the culture system in the lab and provided early detection of negative outcomes 
due to changes in the conditions in the lab (23) . 
It is known that as the number of oocytes retrieved increase, there is an increase in 
the number of mature oocytes, fertilized oocytes and a significant improvement in  
the possibility  of pregnancy (24). In patients who have undergone several ART 
cycles, it has been interpreted that while the chances of pregnancy increase for 
every additional cycle till the 4th cycle, they decreased significantly afterwards (25). 
As the number of embryos transferred increased, there was a parallel increase in the 
pregnancy rates (26) while blood found outside the catheter after an embryo transfer 
was associated with low implantation rates (27). Culture conditions in the lab have 
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been without question been proven to affect the pregnancy outcomes but, there have 
been mixed opinions regarding the effect of personal (doctors and embryologists) in 
the presence of a fixed protocol on the pregnancy rates. 
 
 
Figure 21: Pregnancy rate and ongoing pregnancy as a function of female age 
(2013-2017). Adapted from the German IVF-Registry (D.I.R) 2019, Journal of 




The average age of a patient in this study was 36 years and when compared to the 
DIR, the pregnancy rates over the examined 5 years reveal that they were within the 
range of results in Germany (Figure 21). Initial analysis of the 1126 cycles comparing 
the total cleavage transfers with the total blastocyst transfers reviled no significant 
improvement of the pregnancy rates with blastocyst transfer. Day 2 transfers and 
Day 3 transfer pregnancy rates were also compared and no difference was found. It 
was only after comparing the cleavage vs blastocyst transfer pregnancy rates 
individually for each year where a significant rise in the blastocyst transfer pregnancy 
rate between 2017 and 2018 was found. A simple logistic regression graph depicted 
an increase in the pregnancy rates by 1.1 times each year for both the groups 
between 2014 and 2018.  
A logistic regression graph was then created with an attempt to correct the possible 
bias in the outcome due to the variables explained previously.  The new graph 
showed a 1.4 time increase in the pregnancy rates per year from 2014 to 2018 for 
both groups. Taking into account all the possible reasons for improvement in the 
pregnancy rates form 2014 to 2018, it was concluded that over the years, there was 
no change in the age or medical characteristics of the patients seeking treatment 
and there no alteration in the stimulation protocols used, the method of oocyte 
retrieval or embryo transfer.  
When pregnancy rates for cleavage stage transfers were compared with day 5 
transfers for each individual year, no significance was found but, the logistic 
regression curve showed an improvement in the pregnancy rates from 2014 to 2018 
gradually over the years in both cleavage and blastocyst transfers. As there was 
improvement in pregnancy rates in both the cleavage stage and blastocyst stage, it 
could be assumed that the conditions in the lab that influenced cleavage pregnancy 
rates also influenced Day 5 pregnancy rates. 
 
On evaluation of lab parameters that could have contributed the improvement in 
pregnancy rates, it was observed that, pregnancy rates were significantly higher 
when an ideal blastocyst was transferred compared to a not-ideal blastocyst. But, 
when transfer of ideal and not-ideal cleavage stage embryos were compared, there 
was no significant effect on the pregnancy rates.  
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It has been observed that when the blastocyst morphology is “ideal”, i.e. a higher 
expansion grade, top quality inner cell mass and trophectoderm, it was found to be 
genetically euploid (28). An in-vitro study of the interaction between the endometrium 
and a good or bad quality embryo demonstrated that decidual cells are programmed 
to select embryos that are perceived to be competent to prevent investing energy in 
growth and development of a less viable embryo (29).  Hence, a higher pregnancy 
rate in ideal day 5 embryo transfer group could be explained by increased chances 
of implantation due to apparent euploidy and the active involvement of the 
endometrium as a bio-sensor in helping the ideal blastocysts implant. A year wise 
analysis from 2014 to 2018 showed that the number of ideal day 5 embryos 
increased by 1.5 times every year while the number of non-ideal embryos decreased 
by 0.64 times each year.  
As it was clearly seen that rise of the number of ideal day 5 embryos transferred 
caused the overall improvement in the pregnancy rates over the years and culture of 
a frangible human blastocyst requires sustained stable lab conditions that support 
the growth of the embryo with changing needs, we analysed the changes made in 
the lab that were responsible for this effect. Over 5 years, the 21% oxygen tension in 
the incubator was changed to 5% while shifting from a conventional culture incubator 
to a bench top and then to a time lapse incubator. 
In-vivo, a human embryo develops at a constant temperature of 37°C ±2. The 
constant movement of the embryo through the fallopian tube into the uterus helps in 
the constant supply of fresh substrates to that particular stage of the embryo for its 
metabolism and removal of toxins or wastes the embryo produces over 6 days. The 
requirements of the embryo change as it develops and the fallopian tubes and 
endometrium have mechanisms in place to protect and nourish the growing embryo. 
In the human body, the embryo has a low oxygen (5%) environment and a dynamic 
system around it always maintaining the right pH for its further development (30).   
It is known that a change in the temperature by 2 degrees causes non-reversable 
damage in the spindle of the oocyte causing abnormal cleavage (31). A change in 
the temperature could cause a change in the pH of the media which accounts for  
fragmentation in embryos (32). It has been extensively studied that a low oxygen 
tension (5%) in incubators gives increased blastocyst rates and higher pregnancy 
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rates (33). Hence, when a culture dish with embryos is taken out of an incubator, it is 
exposed to lower room temperature, a change in pH and higher O2 tension than 
normal culminating as a stressful event for the embryo. Embryo assessment during 
its culture in the ART lab is performed by removing it from a conventional/ bench-top 
incubator daily for quality assessment under a microscope by an embryologist. 
While it is universally agreed upon to maintain a narrow range of temperature and 
pH in the incubator to facilitate the optimal growth of embryos, the concentration of 
O2 in the incubator is still a matter of debate in various labs. The physiological 
concentration of oxygen in the fallopian tube and uterus which is the physiological 
home of the embryo is between 2% to 5%. A reduced oxygen tension is one of the 
most potent regulators of embryo function as it plays a critical role in gene 
expression, epigenetics and metabolism of the embryo (34). While blastocyst culture 
under atmospheric oxygen might not only decrease the number of ideal embryos and 
pregnancy rates, it might also have an adverse effect on children born (35). In this 
study, a comparison of the number of ideal embryos produced by each culture 
system showed that the time lapse and the bench top incubators which had 5% 
oxygen culture had a higher ideal day 5 embryo rate and pregnancy rate than the 
conventional incubator which had atmospheric oxygen tension for culture. 
Existing reports indicate although that benchtop incubators have smaller chambers 
and direct heat to try to speed environmental recovery following incubator 
openings/closings providing faster recovery of environmental variables compared to 
conventional incubators, there is no clear advantage of any particular incubator 
based on clinical outcomes (36). The advantages of a time-lapse incubator are that 
embryo development can be continuously monitored without physically removing 
them from the incubator with the advantage of maintaining a stable culture 
environment and limiting the exposure of embryos to changes in gas composition, 
temperature, and movement. Despite evidence to show higher proportion of 
developmentally appropriate day 2 and day 3 embryos in time-lapse compared to 
bench-top incubators (37), no clear consensus has been reached on the benefits of 
uninterrupted embryo culture (38). While some meta-analysis claim significantly 
higher ongoing pregnancy rates and lower early pregnancy losses (39), the 
Cochrane Review of 2019 states that the quality of evidence at present is insufficient 
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to state that time-lapse incubators with uninterrupted culture are better than a 
conventional incubator (40). 
When the 3 different types of incubators were individually compared to each other, 
there was a significant increase in the number of ideal day 5 embryos in the bench-
top and time-lapse incubators compared to the conventional incubator. While, no 
difference in the percentage of ideal day 5 embryo production was found in between 
the bench-top and time-lapse incubators, the most significant difference was seen 
between the time-lapse and the conventional incubator. 
Although in our study, there was an improvement in pregnancy rates as a result of 
increase in the number of ideal blastocysts cultured in the lab due to improvement in 
the lab conditions, the idea of Blastocyst culture for all should be viewed extremely 
critically. As it is known, the lesser the number of embryos developed in a cycle and 
the older the patient, the lower the possibility of a euploid blastocyst developing (41). 
In many countries Preimplantation Genetic Testing -Aneuploidy (PGT-A) is 
performed as a screening method to identify the euploid embryo before transfer by 
trophoblast biopsy of the blastocyst to improve pregnancy chances of the patient and 
prevent transfer of aneuploid embryos. In Germany, only polar body biopsy is 
allowed as a screening method and trophoblast biopsy is allowed only for detection 
of a known genetic disease in the family. The results from the largest randomised 
trial on the chromosomal screening of oocytes before embryo transfer showed failure 
to improve the chance of having a baby (42). Hence, in patients with lesser number 
of oocytes where PGT-A is not possible, it is a matter of debate if cleavage and not a 
blastocyst transfer should be offered as there is no role of selection in these patients.  
 
An increase in the pregnancy rates was seen both in cleavage and blastocyst 
transfer groups with improvement in the culture systems in the lab. However, the 
effect of the improvement was more significant in the blastocyst culture compared to 
cleavage stage culture. It could be speculated that the blastocyst stage is more 
susceptible to changes in the culture environment than cleavage stage. Hence, it 
could be logical in situations where there are sub-optimal conditions in the lab that a 
cleavage stage transfer should be opted for over a blastocyst transfer. 
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Regardless of age, when a day 5 culture was planned, in more than 70 % of the 
patients, an ideal embryo was available for transfer. Whereas when a cleavage 
stage transfer was planned an ideal embryo was available for transfer in under 63% 
of patients. The possible explanation for this difference could be that in the 
blastocyst transfer group, 4 or more embryos were left in culture to identify the one 
with the best development potential for transfer whereas in the cleavage group only 
1, 2 or 3 embryos were left in culture which were then transferred irrespective of their 
development potential.       
There was no association between abortion rates and day of transfer and there was 
no change in the abortion rates over the years. On comparing the abortion rates in 
the day 5 transfer group, no difference was noticed if an ideal or not-ideal day 5 
embryo was transferred. However, the abortion rate if an ideal cleavage stage 
embryo was transferred was significantly lower than if a not-ideal cleavage stage 
embryo was transferred. Although the numbers are low, it can be hypothesised that 
the day 2/3 morphology can predict the chances of abortion in an ART cycle. 
Some studies argue that compared to cleavage stage transfer, blastocyst transfer 
has been associated with a skewed sex ratio in favour of males (19), higher risk of 
preterm delivery (18) and large for gestational age babies (43) while some assert 
that there is no increased risk for these factors (44). The follow up of 70% of the 
pregnant patients (n=197), it was found that there was no difference in the mode of 
delivery (vaginal or caesarean section), week of birth (pre-term or term), sex of the 
baby (male or female), birth weight or health of the baby at birth. 
The HEFA report of all the ART cycles performed in UK clearly shows that the 
number of blastocyst transfers in the UK had increased from an average of 7% in 
2006, 12% in 2008, 25% in 2010 to over 40% in 2012/3 with a steady upward trend. 
Similar to HEFA, our centre increased the blastocyst transfer rate over 5 years with 
21% of the transfers being day 5 transfers in 2014 to 44% in 2018. In the UK, the 35-
37-year-old population with day 5 transfer had a pregnancy rate of 46.8%. The 
higher pregnancy rates compared to this study could be due to the law in UK which 
unlike the German law allows the culture of all the fertilized oocytes and gives the 
ART Lab the liberty to choose the best embryos for transfer and freeze or discard 
extra embryos. In most countries (USA, UK, Spain, Australia and most South 
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American and Asian countries) that report higher pregnancy rates than Germany, 
there are no laws to curb the number of embryos cultured and hinder embryo 
selection. 
The limitation of this study was that the sample size of blastocyst group was 
relatively small and a larger randomized controlled study should be carried out in the 
future to further confirm these findings. There are multiple factors that can affect the 
pregnancy chances in a couple in an ART cycle. While Some have been proven, 
most factors do not have enough strong evidence to be taken into account. In this 
study, effort was made to correct the bias due to a limited number of factors. No all 
















The world is moving towards extended embryo culture (Day 5 - Blastocyst Culture) 
and transfer of human embryos in IVF/ICSI cycles instead of the traditional day 2/3 
(cleavage stage) transfer to improve pregnancy rates in patients seeking treatment 
for infertility. Due to the Embryo protection law preventing embryo selection, it is 
standard in Germany to perform day 2/3 (Cleavage) transfers and seldom, the 
German Middle Way is adopted to perform blastocyst transfers. Although the 
outcome of an ART cycle depends on a multitude of clinical and laboratory factors, 
this study pursued to critically explore the various advantages and disadvantages of 
changing the protocol in a German lab to international standards where blastocyst 
culture is the norm.  
Analysis of 1126 ART cycles that were performed from 2014 to 2018 in the 
University Reproductive Medical Unit of UKSH, Kiel showed that there was an 
improvement in pregnancy rates from 2014 to 2018 in both cleavage stage transfer 
and blastocyst transfer with a 1.4 time increase every year. There was a significant 
rise in the pregnancy rates with blastocyst transfer compared to cleavage stage 
transfer as a direct result of increase in the number of morphologically ideal 
blastocysts cultured in the lab due to improvement in the lab culture conditions by 
shifting from conventional incubators which had atmospheric oxygen tension (21%) 
to the sustained stable culture conditions (temperature and pH) of bench-top and 
time-lapse incubators which had 5% oxygen. The improvement in culture conditions 
had a higher impact on day 5 rather than day 2/3 culture as it could be speculated 
that the blastocyst stage is more susceptible to changes in the culture environment 
than cleavage stage. Hence, it would be logical in situations where there are sub-
optimal conditions in the lab that a cleavage stage transfer should be opted for over 
a blastocyst transfer. 
Regardless of age, significantly more patients had an ideal day 5 embryos compared 
to a day 2/3 embryos possibly because in the blastocyst transfer group, 4 or more 
embryos were left in culture to identify the one with the best development potential 
for transfer whereas in the cleavage group only 1, 2 or 3 embryos were left in culture 
which were then transferred irrespective of their development potential. While ideal 
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day 5 embryos were an excellent tool to assess the culture system in the lab and 
were associated with higher pregnancy rates, not-ideal cleavage stage embryos 
were associated with higher abortion rates.  
Although we had significant improvement in our pregnancy rates with changeover to 
blastocyst transfers, they were not as high as those in the UK. Perhaps because 
unlike the German law, culture of all the fertilized oocytes gave the ART Lab the 
liberty to choose the best embryos for transfer and freeze or discard extra embryos. 
The limitation of this study was that the sample size of blastocyst group was 
relatively small and a larger randomized controlled study should be carried out in the 
future to further confirm these findings.  
In conclusion, if an IVF Unit would want to improve its pregnancy rates by shifting to 
blastocyst culture, it would be advisable to monitor and to improve its culture 
systems till the ideal blastocyst rate is >60% before its wider application. 
Furthermore, a change in the German Law to support wider application of Blastocyst 
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